徳島大学 / 教育研究者総覧 --- 西條康代

検索:

徳島大学 ⟩ 大学院医歯薬学研究部 ⟩ 医学域 ⟩ 先端医学教育研究プロジェクト ⟩
徳島大学 ⟩ 大学院医歯薬学研究部 ⟩ 医学域 ⟩ 医科学部門 ⟩ 病理系 ⟩ 分子病理学 ⟩
徳島大学 ⟩ 医学部 ⟩ 医学科 ⟩ 器官病態修復医学講座 ⟩ 分子病理学分野 ⟩

(researchmapへのインポート用ファイル) [PDF解説] [researchmapへの自動反映について]

研究活動

専門分野

研究テーマ

著書・論文

学術論文(審査論文):

1.	Minoru Matsumoto, Takuya Ohmura, Yuto Hanibuchi, Mayuko Shimizu, Yasuyo Saijo, Hirohisa Ogawa, Ryuichiro Miyazawa, Junko Morimoto, Koichi Tsuneyama, Mitsuru Matsumoto and Takeshi Oya : AIRE illuminates the feature of medullary thymic epithelial cells in thymic carcinoma., Cancer Medicine, 2023. (要約) Despite the clear distinction between cortical (cTECs) and medullary thymic epithelial cells (mTECs) in physiology, the cell of origin of thymic carcinomas (TCs) and other thymic epithelial tumors remained enigmatic. We addressed this issue by focusing on AIRE, an mTEC-specific transcriptional regulator that is required for immunological self-tolerance. We found that a large proportion of TCs expressed AIRE with typical nuclear dot morphology by immunohistochemistry. AIRE expression in TCs was supported by the RNA-seq data in the TCGA-THYM database. Furthermore, our bioinformatics approach to the recent single-cell RNA-seq data on human thymi has revealed that TCs hold molecular characteristics of multiple mTEC subpopulations. In contrast, TCs lacked the gene signatures for cTECs. We propose that TCs are tumors derived from mTECs. (出版サイトへのリンク) ● Publication site (DOI): 10.1002/cam4.5777 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36912123 ● Search Scopus @ Elsevier (PMID): 36912123 ● Search Scopus @ Elsevier (DOI): 10.1002/cam4.5777 (DOI: 10.1002/cam4.5777, PubMed: 36912123)
2.	Satoshi Sumida, Mayuko Shimizu, Yuko Miyakami, Takumi Kakimoto, Tomoko Kobayashi, Yasuyo Saijo, Minoru Matsumoto, Hirohisa Ogawa, Takeshi Oya, Yoshimi Bando, Hisanori Uehara, Shu Taira, Mitsuo Shimada and Koichi Tsuneyama : Histological and immunohistochemical analysis of epithelial cells in epidermoid cysts in intrapancreatic accessory spleen., The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 251-259, 2023. (要約) Novel histological features of epithelial cells of ECIPAS were indicated. Although more cases need to be evaluated, we propose that the cause of ECIPAS may be different from that of pancreatic ductal origin. J. Med. Invest. 70 : 251-259, February, 2023. (キーワード) Humans / Epidermal Cyst / Spleen / Pancreatic Diseases / Epithelial Cells / Immunohistochemistry (徳島大学機関リポジトリ) ● Metadata: 118205 (出版サイトへのリンク) ● Publication site (DOI): 10.2152/jmi.70.251 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37164730 ● Search Scopus @ Elsevier (PMID): 37164730 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.70.251 (徳島大学機関リポジトリ: 118205, DOI: 10.2152/jmi.70.251, PubMed: 37164730)
3.	Souichiro Sasa, Hiroaki Inoue, INUI Tomohiro, Naoki Miyamoto, Mariko Aoyama, Kazumasa Okumura, Hiroaki Toba, Takahiro Yoshida, Tezuka Miki, Hirose Chieko, Yasuyo Saijo, Hisanori Uehara, Izumori Ayumi, Takahashi Masako, Sasa Mitsunori and Hiromitsu Takizawa : Axillary lymphangioma that developed following COVID-19 vaccination: a case report, Surgical Case Reports, Vol.8, No.1, 131, 2022. (要約) Extensive vaccination programs are being implemented worldwide for coronavirus disease 2019 (COVID-19). With the spread of vaccination, swelling of the lymph nodes after vaccination is frequently seen. We encountered a patient who developed left axillary lymphadenoma following vaccine administration. The patient was a Japanese woman in her 80 s who had previously undergone surgery for right breast cancer. She received two injections of the Pfizer-BioNTech COVID-19 vaccine in her left arm. Approximately 3 months later, she complained of left axillary swelling, and imaging resulted in a diagnosis of left axillary lymphangioma. In accordance with the patient's wishes, we performed axillary mass resection. The pathological diagnosis was lymphangioma. Our examination findings indicated that congestion of the axillary lymph vessels might have been caused by upper-arm injections of the COVID-19 vaccine. (出版サイトへのリンク) ● Publication site (DOI): 10.1186/s40792-022-01488-5 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35798903 ● Search Scopus @ Elsevier (PMID): 35798903 ● Search Scopus @ Elsevier (DOI): 10.1186/s40792-022-01488-5 (DOI: 10.1186/s40792-022-01488-5, PubMed: 35798903)

学術論文(紀要・その他):

1.	Yosuke Iwakawa, Masaaki Nishi, Yuuma Wada, Kouzou Yoshikawa, Chie Takasu, Mitsuo Shimada, Yasuyo Saijo, Minoru Matsumoto, Takeshi Oya and Hisanori Uehara : Pleomorphic type undifferentiated gastric sarcoma, report of a case., Clinical Journal of Gastroenterology, Vol.16, No.1, 20-25, 2023. (要約) Reports on pleomorphic type of undifferentiated sarcoma (PUS) originating from the gastrointestinal tract, especially the stomach, are extremely rare. We herein report a case of pleomorphic type undifferentiated gastric sarcoma. The patient was a 67-year-old woman. The chief complaint was upper abdominal pain. Upper gastrointestinal endoscopy, ultrasonography, and contrast-enhanced computed tomography showed two submucosal tumors at the greater curvature of the fundus and the lesser curvature of the gastric angle. Endoscopic ultrasound-guided fine-needle aspiration revealed a c-kit-negative spindle cell tumor at the greater curvature of the fundus. Total gastrectomy, splenectomy, and partial resection of the diaphragm and liver were performed. One lesion had invaded the lateral segment of the liver, left diaphragm and spleen. The postoperative course was uneventful. Histopathological and immunohistochemical examinations of the resected specimen revealed PUS. Peritoneal dissemination was detected at 8 months after surgery. However, no effective therapeutic agents were adopted for chemotherapy. The patient had poor performance status due to disease progression and underwent best supportive care. The patient died 10 months after surgery. This case highlights the imaging, histological diagnosis, and treatment strategy for PUS originating from the stomach. Surgeons should be aware of PUS as a differential diagnosis in cases with submucosal tumor of the stomach. (キーワード) Female / Humans / Aged / Stomach Neoplasms / Gastrectomy / Sarcoma / Endoscopy, Digestive System / Liver Neoplasms (出版サイトへのリンク) ● Publication site (DOI): 10.1007/s12328-022-01729-y (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36289170 ● Search Scopus @ Elsevier (PMID): 36289170 ● Search Scopus @ Elsevier (DOI): 10.1007/s12328-022-01729-y (DOI: 10.1007/s12328-022-01729-y, PubMed: 36289170)

総説・解説:

1.	Yoshimi Bando, Tomoko Kobayashi, Yuko Miyakami, Satoshi Sumida, Takumi Kakimoto, Yasuyo Saijo and Hisanori Uehara : Triple-negative breast cancer and basal-like subtype : Pathology and targeted therapy., The Journal of Medical Investigation : JMI, Vol.68, No.3.4, 213-219, 2021. (要約) Triple-negative breast cancer (TNBC) is a heterogenous disease. For personalized medicine, it is essential to identify and classify tumor subtypes to develop effective therapeutic strategies. Although gene expression profiling has identified several TNBC subtypes, classification of these tumors remains complex. Most TNBCs exhibit an aggressive phenotype, but some rare types have a favorable clinical course. In this review, we summarize the classification and characteristics related to the various TNBC subtypes, including the rare types. Therapeutic methods that are suitable for each subtype are also discussed. Of the intrinsic breast cancer subtypes identified by gene expression analysis, the basal-like subtype specifically displayed decreased expression of an estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) cluster. We also present results that characterize the TNBC and basal-like phenotypes. TNBC may be categorized into four major classes : basal-like, immune-enriched, mesenchymal, and luminal androgen receptor. Therapeutic strategies for each subtype have been proposed along with newly approved targeted therapies for TNBC, such as immune checkpoint inhibitors. Understanding the classification of TNBC based on gene expression profiling in association with clinicopathological factors will facilitate accurate pathological diagnosis and effective treatment selection. J. Med. Invest. 68 : 213-219, August, 2021. (キーワード) Gene Expression Profiling / Humans / Receptors, Estrogen / Triple Negative Breast Neoplasms (徳島大学機関リポジトリ) ● Metadata: 116478 (出版サイトへのリンク) ● Publication site (DOI): 10.2152/jmi.68.213 (文献検索サイトへのリンク) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34759133 ● Search Scopus @ Elsevier (PMID): 34759133 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.68.213 (徳島大学機関リポジトリ: 116478, DOI: 10.2152/jmi.68.213, PubMed: 34759133)

国内講演発表:

1.	西條康代, 常山幸一, 松本穣, 尾矢剛志 : 悪性転化を来した biliary adenofibroma の1例, 第113回日本病理学会総会, 2024年3月.
2.	松本穣, 西條康代, 尾矢剛志 : S2900, 日本病理学会中国四国支部学術集会(Web開催)第142回スライドカンファレンス, 2023年11月.
3.	西條康代, 尾矢剛志, 松本穣 : S2883 下垂体腫瘍, 日本病理学会中国四国支部学術集会(Web開催)第141回スライドカンファレンス, 2023年6月.
4.	松本穣, 西條康代, 清水真祐子, 小川博久, 常山幸一, 松本満, 尾矢剛志 : 胸腺癌におけるAIRE発現と胸腺髄質上皮細胞との類似性, 日本病理学会会誌, Vol.111, No.1, 243, 2022年4月.
5.	西條康代, 坂東良美, 尾矢剛志, 松本穣, 上原久典 : S2838 頭蓋内腫瘍, 日本病理学会中国四国支部学術集会第136回スライドカンファレンス, 2021年10月.
6.	庄野隆志, 井上聖也, 南城和正, 西條康代, 牧秀則, 青山万理子, 西野豪志, 後藤正和, 吉田卓弘, 滝沢宏光, 丹黒章 : 術前化学療法に効果を示し，根治手術を施行した進行食道粘表皮癌の1例, 第75回日本食道学会学術集会(ハイブリッド開催), 2021年9月.

科学研究費補助金 (KAKEN Grants Database @ NII.ac.jp)

研究者番号（00972952）による検索